Vitals
- Healthcare shed 28,000 jobs in February — the first decline in over 4 years, cracking the sector that single-handedly propped up the US labor market
- RAND quantifies OBBBA Medicaid cuts at $665 billion through 2034; rural and safety-net hospitals entering crisis planning
- CMS unveils ACCESS Model at ViVE 2026 — a decade-long initiative tying chronic disease management to outcomes-based reimbursement
- ChatGPT Health under-triaged 52% of emergencies in a Nature Medicine study, giving regulators ammunition to slow consumer AI deployment
- 2026 Medicare fee schedule includes AI reimbursement — 68% of providers projected to use AI tools by December1
- FDA faces operational crisis as government shutdown halts new drug, biologic, and device submissions
Peaks
CMS ACCESS Model Launches 10-Year Chronic Care Play
Unveiled at ViVE 2026, this is the biggest structural signal for value-based care since the Medicare Shared Savings Program (MSSP). The Center for Medicare and Medicaid Innovation (CMMI) is creating a decade-long initiative that ties chronic disease management to outcomes-based reimbursement with scalable technology. Digital health companies with chronic care platforms just received a 10-year runway. For health systems still building value-based infrastructure, this is the clearest federal on-ramp available.2
Why it matters: A 10-year model removes the uncertainty that killed previous CMMI experiments. Capital can now underwrite chronic care platforms with confidence in the reimbursement timeline.
AI Reimbursement Pathways Crystallizing
The 2026 Medicare fee schedule now includes improved reimbursement for AI-enhanced services. Federal stakeholders are pushing the Centers for Medicare and Medicaid Services (CMS) to align payment models with AI's clinical value across efficiency, prevention, and care coordination. The Office of the National Coordinator for Health IT (ONC) projects 68% of providers will use AI tools for at least one clinical function by December 2026. Separately, MWW Health launched HealthPulse, an AI-powered policy intelligence platform, signaling that regulatory complexity around healthcare AI is now large enough to sustain its own software market.3
Why it matters: The gap between AI adoption and AI reimbursement is finally closing. Organizations that positioned early for AI-enhanced workflows now have a payment pathway. Those still in pilot mode are running out of runway.
Health Systems Insourcing Revenue Cycle Management
CommonSpirit Health sold its 23.8% stake in Tenet Healthcare's Conifer subsidiary for $540 million and is bringing revenue cycle management (RCM) fully in-house over 10 months. This is a structural signal: large systems are betting they can manage RCM cheaper internally, with AI-augmented vendors replacing legacy outsourcers. Senior care capital is also surging, with Sage raising $65 million in a Series C led by Goldman Sachs Growth Equity for AI-powered senior care insights, and Salma Health launching with $80 million for brain health.4
Why it matters: The RCM outsourcing model that dominated the last decade is reversing. Winners will be AI-enabled vendors small enough to plug into existing systems, not legacy platforms that require full workflow replacement.
Troughs
Healthcare Jobs Collapse: First Decline in Over 4 Years
Healthcare shed 28,000 jobs in February, nearly a third of the 92,000 total US jobs lost. The sector added 693,000 of the 116,000 total jobs created in 2025. Without healthcare, the US economy would have lost 570,000 jobs last year. Now the last pillar has cracked. Total payroll change from May 2025 through February 2026: negative 19,000. Unemployment spiked to 4.4%. Bureau of Labor Statistics (BLS) data confirms nursing strikes contributed, but the underlying vulnerability is structural.5
Why it matters: Healthcare was never recession-proof. It was recession-last. The narrative that the sector could absorb economic shocks indefinitely just broke. Workforce planning models built on permanent growth assumptions need immediate revision.
OBBBA Medicaid Cuts Quantified at $665 Billion
The RAND Corporation released a state-by-state analysis projecting $665 billion in total Medicaid funding reduction through 2034 under the One Big Beautiful Bill Act (OBBBA). MercyOne in Des Moines is already announcing layoffs. Rural and safety-net hospitals are entering crisis planning. CNN reports Democrats are building 2026 midterm campaigns around hospital layoffs tied to these cuts, shifting healthcare spending from policy debate to electoral politics. An estimated 7.6 million fewer people will be insured by 2034.6
Why it matters: This number moves the conversation from "potential cuts" to "quantified crisis." Every health system chief financial officer doing five-year planning now has a RAND-validated model showing exactly how much federal revenue is at risk, by state.
AI Triage Reliability Failing at Scale
A Nature Medicine study found ChatGPT Health under-triaged 52% of medical emergencies, meaning it classified urgent situations as less severe than they actually were. Conditions like diabetic ketoacidosis and impending respiratory failure were directed to schedule a doctor's appointment within 24 to 48 hours instead of going to the emergency room. The system did triage textbook emergencies like stroke and anaphylaxis correctly, but the nuanced situations where clinical judgment matters most were where it failed. Managed Healthcare Executive separately warned of "automation complacency" where clinical staff accept AI outputs without review, noting that vendor contracts do not transfer clinical liability.7
Why it matters: The validation gap is becoming the industry's most consequential bottleneck. AI agents are proliferating faster than evidence frameworks can assess them. Organizations deploying clinical AI without rigorous internal validation are carrying uninsured liability.
Trends
Federal Health Infrastructure Fracturing on Multiple Fronts
The Food and Drug Administration (FDA) is in operational crisis, with new submissions requiring user fees halted by the government shutdown. The Department of Government Efficiency (DOGE) now manages grants.gov posting permissions, effectively freezing National Institutes of Health (NIH) grant peer reviews and basic research funding. The US Preventive Services Task Force (USPSTF) postponed its meeting. The Department of Health and Human Services (HHS) canceled the US autism advisory board's March session. The institutional scaffolding that guides clinical practice, funds research, and reviews drug safety is weakening simultaneously.8
Why it matters: Organizations still dependent on federal stability for revenue, research funding, or regulatory guidance are exposed. The organizations building independent capacity, including revenue diversification, direct-to-patient channels, and internally validated AI, will outperform.
AI Governance Emerging as Competitive Moat
The gap between AI ambition and compliance readiness keeps widening. Organizations that solve governance first will scale faster, attract better capital, and avoid the liability traps others fall into. This is the quiet differentiator of 2026. From AI reimbursement alignment to prior authorization reform (electronic standardization is coming) to state-level AI disclosure laws in Texas, the regulatory surface area is expanding fast enough to spawn entirely new product categories and advisory businesses.9
Why it matters: Governance is no longer a compliance checkbox. It is the infrastructure that determines which organizations can scale AI and which will stall. The vendor that can prove safety, accuracy, and auditability wins the contract. The one that cannot gets cut from evaluation cycles.
Two-Speed Healthcare Economy Solidifying
Capital is flowing aggressively into AI-enabled aging care and diagnostics. Agilent Technologies announced a $950 million all-cash acquisition of Biocare Medical, a clinical pathology firm. Senior care AI raised $145 million in a single week. Meanwhile, Medicaid-dependent systems face existential margin pressure from $665 billion in projected federal cuts. Home health is emerging as the low-friction deployment zone for clinical AI because regulatory burden is lighter than acute care. CommonSpirit Health at Home's chief executive described their 2026 strategy in three words: "AI, AI, and AI."10
Why it matters: The market is bifurcating into systems serving commercial and senior populations (attracting premium valuations and venture capital) and systems serving Medicaid populations (facing federal cuts with no capital buffer). The gap will widen through 2026.
So What?
For Professionals
Three things changed this week. First, the healthcare jobs engine stalled. If your organization has been hiring on the assumption that healthcare always grows, that assumption just broke. Second, the ACCESS Model gives chronic care and value-based care professionals a 10-year federal runway. If you work in primary care, behavioral health, or chronic disease management, this is your signal to invest in outcomes infrastructure. Third, the AI triage study means clinical staff will be asked to do more validation work, not less, even as AI tools multiply. Governance training is no longer optional.
For Leaders and Operators
The $665 billion OBBBA number is now your planning baseline. Map your revenue mix against RAND's state-by-state projections immediately. The political window to reverse these cuts is closing as they become campaign ammunition rather than negotiable policy. On the AI front, reimbursement is finally following the technology, but only for organizations with governance frameworks in place. The FDA crisis means drug and device pipelines are freezing; factor supply chain delays into your 2026 procurement planning.
For Builders and Investors
The ACCESS Model is the clearest 10-year signal the federal government has sent to healthcare technology in years. Chronic care platforms with outcomes measurement and interoperability built in just became the safest long-duration bets in digital health. The AI governance gap is creating a new product category; every vendor showing agents at HIMSS this week will need validation infrastructure by year-end. Home health at the intersection of AI deployment and lower regulatory friction is the deployment wedge. The $145 million in senior care AI funding in one week tells you where the market is heading.
On the Calendar
- HIMSS 2026 — continues through March 13, Las Vegas
- BHC Boston Q1 Mixer — March 19
- BHC Baltimore Q1 Mixer — March 20
- BHC Detroit Q1 Mixer — March 26
- BHC NYC Q1 Mixer — March 27